- Active not recruitingPHASE3
Long Term Extension Study in Patients With Primary Hyperoxaluria
This study offers long-term treatment with DCR-PHXC for people, including children, with Primary Hyperoxaluria (PH). It checks if the treatment is safe and works well over time for this rare genetic kidney condition.
For: Primary Hyperoxaluria Type 1 (PH1) · Primary Hyperoxaluria Type 2 (PH2) · Kidney DiseasesUnited States · Australia · Canada - RecruitingPHASE2
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
This study is testing a new medicine, DCR-PHXC, for people with a rare kidney disease called Primary Hyperoxaluria Type 1 (PH1) who also have severe kidney problems. It aims to see how safe and effective the medicine is.
For: Primary Hyperoxaluria Type 1 · End Stage Renal DiseaseUnited States · France · Germany